Abstract
United States Diabetes Care Devices Market Analysis & Forecasts to 2015
Summary
This report is an essential source for in-depth information and data relating
to the US diabetes care devices market. It also offers detailed and
comprehensive coverage of market revenue, volume, distribution and company
share information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the diabetes care devices
market in the US.
Scope
- The report provides Diabetes care devices market information broken down
into detailed categories and segments in the US.
- Total revenues,
products sold, end users, and average pricing.
- Market shares of all the
key competitors.
- Key pipeline products that are set to shape the
market, broken down by sector.
- Information on the top medical equipment
companies in the sector in the country covering business description,
strategic analysis, and financial information.
- Healthcare structure,
regulatory environment, approval process, pricing trends and
reimbursement.
- Product and brand updates, strategy changes, R&D
projects, corporate expansions and contractions and regulatory changes.
-
Key mergers and acquisitions, partnerships, private equity investments and
IPOs.
- Customer, hospitals and physicians data.
Reasons to buy
- Gain a strong understanding of the diabetes care devices market in the
US.
- Evaluate and compare the attractiveness of the market in the
country.
- Identify growth segments and opportunities in each industry
sector within the country.
- Evaluate the pipeline of key products that
will change the sector, and identify threats and opportunities before the
products are launched in the country.
- Analyze the competitiveness of the
market in the country and identify hotspots.
- Develop strategies based
on the latest product, brand, expansion and research and development news in
the country.
- Do deals with an understanding of how competitors are
financed, and the mergers and partnerships that have shaped the market in the
country.
- Identify and analyze the strengths and weaknesses of the
industry incumbents in the country.
Table of Contents
1.1 List of Tables
Table 1: United States Healthcare Expenditure,
2003-2010 19
Table 2: United States Healthcare Expenditure by Age (per
person), 2000-2003 20
Table 3: United States Healthcare Expenditure by Sex
(per person), 2000-2003 20
Table 4: United States Healthcare Expenditure
by Race (per person), 2000-2003 21
Table 5: United States Personal
Healthcare Expenditure by Type, 2000-2004 21
Table 6: United States
Personal Healthcare Expenditure by Source, 2000-2004 22
Table 7: Total
Number of Doctors in the United States, 2003-2010 25
Table 8: Number of
Doctors by Specialty in the United States, 2003-2010 26
Table 9: Doctors
by Region (Number per 10,000 Civilian Population), 2002-2004 27
Table 10:
Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.)
28
Table 11: Total Hospitals in the United States, 2000-2004 28
Table
12: Community Hospitals by Number of Beds in the United States, 2000-2004
29
Table 13: Number of Hospital Beds in the United States, 2000-2004
29
Table 14: Number of Hospital Beds by Range in the United States,
2000-2004 29
Table 15: United States Healthcare Trade Statistics,
2001-2006 30
Table 16: Medical Equipment Registration Fee in United
States, 2007 37
Table 17: Medical Device Approval Time in United States,
2004 37
Table 18: Diabetes Care Devices, United States, Overall
Revenue ($ mn), Historic, 2000-2008 42
Table 19: Diabetes Care
Devices, United States, Overall Revenue ($ mn), Forecast, 2008-2015 43
Table 20: Diabetes Care Devices, United States, Category Volume (Units),
Historic, 2000-2008 44
Table 21: Diabetes Care Devices, United
States, Category Volume (Units), Forecast, 2008-2015 45
Table 22: Diabetes
Care Devices, United States, Portfolio Analysis, 2000-2015 46
Table 23:
Diabetes Care Devices, United States, Company Share by Revenue ($ mn),
2006-2007 48
Table 24: Glucose Monitoring, United States, Revenue ($
mn) by Segment, Historic, 2000-2008 50
Table 25: Glucose Monitoring,
United States, Revenue ($ mn) by Segment, Forecast, 2008-2015 51
Table 26:
Blood Glucose Meters, United States, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 52
Table 27: Blood Glucose Meters, United States,
Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 53
Table 28:
Glucose Monitoring, United States, Volume (Units), Historic, 2000-2008 54
Table 29: Glucose Monitoring, United States, Volume (Units), Forecast,
2008-2015 55
Table 30: Glucose Monitoring, United States, Cross
Segment Analysis, 2000-2015 56
Table 31: Glucose Monitoring, United
States, Average Price ($), Historic, 2000-2008 57
Table 32: Glucose
Monitoring, United States, Average Price ($), Forecast, 2008-2015 57
Table
33: Glucose Monitoring, United States, Distribution Share by Revenue
($mn), 2007-2008 58
Table 34: Glucose Monitoring, United States,
Company Share by Revenue ($ mn), 2006-2007 59
Table 35: Insulin
Delivery, United States, Revenue ($ mn) by Segment, Historic, 2000-2008 61
Table 36: Insulin Delivery, United States, Revenue ($ mn) by Segment,
Forecast, 2008-2015 62
Table 37: Insulin Delivery, United States,
Volume (Units), Historic, 2000-2008 63
Table 38: Insulin Delivery,
United States, Volume (Units), Forecast, 2008-2015 64
Table 39:
Insulin Delivery, United States, Cross Segment Analysis, 2000-2015 65
Table 40: Insulin Delivery, United States, Average Price ($), Historic,
2000-2008 66
Table 41: Insulin Delivery, United States, Average Price
($), Forecast, 2008-2015 66
Table 42: Insulin Delivery, United
States, Distribution Share by Revenue ($mn), 2007-2008 68
Table 43:
Insulin Delivery, United States, Company Share by Revenue ($ mn), 2006-2007
69
Table 44: LifeScan, Inc. Pipeline Products by Equipment Type
71
Table 45: LifeScan, Inc. Pipeline Products By Development Stage
71
Table 46: LifeScan, Inc. Pipeline Products By Therapy Area 72
Table 47: LifeScan, Inc. Pipeline Products By Clinical Trials 72
Table 48: LifeScan, Inc. Pipeline Products By News Summary 72
Table
49: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 77
Table 50: F. Hoffmann-La Roche Ltd Pipeline Products By Development Stage
77
Table 51: F. Hoffmann-La Roche Ltd Pipeline Products By Therapy
Area 77
Table 52: Novo Nordisk A/S Pipeline Products by Equipment
Type 78
Table 53: Novo Nordisk A/S Pipeline Products By Development
Stage 78
Table 54: Novo Nordisk A/S Pipeline Products By Therapy Area
78
Table 55: Novo Nordisk A/S Pipeline Products By Clinical Trials
79
Table 56: Abbott Laboratories Pipeline Products by Equipment Type
83
Table 57: Abbott Laboratories Pipeline Products By Development
Stage 83
Table 58: Abbott Laboratories Pipeline Products By Therapy
Area 83
Table 59: Abbott Laboratories Pipeline Products By Clinical
Trials 84
Table 60: Abbott Laboratories Pipeline Products By News
Summary 84
Table 61: Bayer HealthCare AG Pipeline Products by
Equipment Type 88
Table 62: Bayer HealthCare AG Pipeline Products By
Development Stage 89
Table 63: Bayer HealthCare AG Pipeline Products
By Therapy Area 89
Table 64: Bayer HealthCare AG Pipeline Products By
News Summary 89
Table 65: Medtronic, Inc. Pipeline Products by
Equipment Type 93
Table 66: Medtronic, Inc. Pipeline Products By
Development Stage 93
Table 67: Medtronic, Inc. Pipeline Products By
Therapy Area 94
Table 68: Medtronic, Inc. Pipeline Products By
Clinical Trials 94
Table 69: Eli Lilly and Company Pipeline Products
by Equipment Type 99
Table 70: Eli Lilly and Company Pipeline
Products by Development Stage 99
Table 71: Eli Lilly and Company
Pipeline Products by Therapy Area 99
Table 72: Eli Lilly and Company
Pipeline Products by Clinical Trials 99
Table 73: Eli Lilly and
Company Pipeline Products by News Summary 99
Table 74: AgaMatrix,
Inc. Pipeline Products by Equipment Type 105
Table 75: AgaMatrix,
Inc. Pipeline Products By Development Stage 105
Table 76: AgaMatrix,
Inc. Pipeline Products By Therapy Area 105
Table 77: DexCom, Inc.
Pipeline Products by Equipment Type 106
Table 78: DexCom, Inc.
Pipeline Products By Development Stage 106
Table 79: DexCom, Inc.
Pipeline Products By Therapy Area 107
Table 80: DexCom, Inc. Pipeline
Products By News Summary 107
Table 81: Freedom Meditech, Inc.
Pipeline Products by Equipment Type 108
Table 82: Freedom Meditech,
Inc. Pipeline Products By Development Stage 108
Table 83: Freedom
Meditech, Inc. Pipeline Products By Therapy Area 108
Table 84:
GlucoLight Corporation Pipeline Products by Equipment Type 109
Table 85:
GlucoLight Corporation Pipeline Products By Development Stage 109
Table
86: GlucoLight Corporation Pipeline Products By Therapy Area 109
Table 87: GlucoLight Corporation Pipeline Products By Clinical Trials
110
Table 88: GlucoLight Corporation Pipeline Products By News
Summary 110
Table 89: iSense Corporation Pipeline Products by
Equipment Type 111
Table 90: iSense Corporation Pipeline Products By
Development Stage 111
Table 91: iSense Corporation Pipeline Products
By Therapy Area 112
Table 92: iSense Corporation Pipeline Products By
News Summary 112
Table 93: Sensys Medical, Inc. Pipeline Products by
Equipment Type 113
Table 94: Sensys Medical, Inc. Pipeline Products
By Development Stage 113
Table 95: Sensys Medical, Inc. Pipeline
Products By Therapy Area 114
Table 96: Sensys Medical, Inc. Pipeline
Products By Clinical Trials 114
Table 97: Mediscience Technology
Acquires SensiVida Medical Systems 115
Table 98: Edwards Lifesciences
Enters Into An Agreement With DexCom 116
Table 99: USD to Local
Currency, Average Exchange Rate 2008 132
1.1 List of Tables
Table
1: United States Healthcare Expenditure, 2003-2010 19
Table 2: United
States Healthcare Expenditure by Age (per person), 2000-2003 20
Table 3:
United States Healthcare Expenditure by Sex (per person), 2000-2003 20
Table 4: United States Healthcare Expenditure by Race (per person), 2000-2003
21
Table 5: United States Personal Healthcare Expenditure by Type,
2000-2004 21
Table 6: United States Personal Healthcare Expenditure by
Source, 2000-2004 22
Table 7: Total Number of Doctors in the United
States, 2003-2010 25
Table 8: Number of Doctors by Specialty in the United
States, 2003-2010 26
Table 9: Doctors by Region (Number per 10,000
Civilian Population), 2002-2004 27
Table 10: Doctors by Region (Number per
10,000 Civilian Population), 2002-2004 (Cont.) 28
Table 11: Total
Hospitals in the United States, 2000-2004 28
Table 12: Community Hospitals
by Number of Beds in the United States, 2000-2004 29
Table 13: Number of
Hospital Beds in the United States, 2000-2004 29
Table 14: Number of
Hospital Beds by Range in the United States, 2000-2004 29
Table 15: United
States Healthcare Trade Statistics, 2001-2006 30
Table 16: Medical
Equipment Registration Fee in United States, 2007 37
Table 17: Medical
Device Approval Time in United States, 2004 37
Table 18: Diabetes
Care Devices, United States, Overall Revenue ($ mn), Historic, 2000-2008
42
Table 19: Diabetes Care Devices, United States, Overall Revenue ($
mn), Forecast, 2008-2015 43
Table 20: Diabetes Care Devices, United
States, Category Volume (Units), Historic, 2000-2008 44
Table 21:
Diabetes Care Devices, United States, Category Volume (Units), Forecast,
2008-2015 45
Table 22: Diabetes Care Devices, United States, Portfolio
Analysis, 2000-2015 46
Table 23: Diabetes Care Devices, United
States, Company Share by Revenue ($ mn), 2006-2007 48
Table 24:
Glucose Monitoring, United States, Revenue ($ mn) by Segment, Historic,
2000-2008 50
Table 25: Glucose Monitoring, United States, Revenue ($
mn) by Segment, Forecast, 2008-2015 51
Table 26: Blood Glucose
Meters, United States, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
52
Table 27: Blood Glucose Meters, United States, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 53
Table 28: Glucose Monitoring,
United States, Volume (Units), Historic, 2000-2008 54
Table 29:
Glucose Monitoring, United States, Volume (Units), Forecast, 2008-2015 55
Table 30: Glucose Monitoring, United States, Cross Segment Analysis,
2000-2015 56
Table 31: Glucose Monitoring, United States, Average
Price ($), Historic, 2000-2008 57
Table 32: Glucose Monitoring,
United States, Average Price ($), Forecast, 2008-2015 57
Table 33:
Glucose Monitoring, United States, Distribution Share by Revenue ($mn),
2007-2008 58
Table 34: Glucose Monitoring, United States, Company
Share by Revenue ($ mn), 2006-2007 59
Table 35: Insulin Delivery,
United States, Revenue ($ mn) by Segment, Historic, 2000-2008 61
Table 36:
Insulin Delivery, United States, Revenue ($ mn) by Segment, Forecast,
2008-2015 62
Table 37: Insulin Delivery, United States, Volume
(Units), Historic, 2000-2008 63
Table 38: Insulin Delivery, United
States, Volume (Units), Forecast, 2008-2015 64
Table 39: Insulin
Delivery, United States, Cross Segment Analysis, 2000-2015 65
Table 40:
Insulin Delivery, United States, Average Price ($), Historic, 2000-2008
66
Table 41: Insulin Delivery, United States, Average Price ($),
Forecast, 2008-2015 66
Table 42: Insulin Delivery, United States,
Distribution Share by Revenue ($mn), 2007-2008 68
Table 43: Insulin
Delivery, United States, Company Share by Revenue ($ mn), 2006-2007 69
Table 44: LifeScan, Inc. Pipeline Products by Equipment Type 71
Table
45: LifeScan, Inc. Pipeline Products By Development Stage 71
Table
46: LifeScan, Inc. Pipeline Products By Therapy Area 72
Table 47:
LifeScan, Inc. Pipeline Products By Clinical Trials 72
Table 48:
LifeScan, Inc. Pipeline Products By News Summary 72
Table 49: F.
Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 77
Table 50:
F. Hoffmann-La Roche Ltd Pipeline Products By Development Stage 77
Table
51: F. Hoffmann-La Roche Ltd Pipeline Products By Therapy Area 77
Table 52: Novo Nordisk A/S Pipeline Products by Equipment Type 78
Table 53: Novo Nordisk A/S Pipeline Products By Development Stage 78
Table 54: Novo Nordisk A/S Pipeline Products By Therapy Area 78
Table
55: Novo Nordisk A/S Pipeline Products By Clinical Trials 79
Table
56: Abbott Laboratories Pipeline Products by Equipment Type 83
Table
57: Abbott Laboratories Pipeline Products By Development Stage 83
Table 58: Abbott Laboratories Pipeline Products By Therapy Area 83
Table 59: Abbott Laboratories Pipeline Products By Clinical Trials
84
Table 60: Abbott Laboratories Pipeline Products By News Summary
84
Table 61: Bayer HealthCare AG Pipeline Products by Equipment Type
88
Table 62: Bayer HealthCare AG Pipeline Products By Development
Stage 89
Table 63: Bayer HealthCare AG Pipeline Products By Therapy
Area 89
Table 64: Bayer HealthCare AG Pipeline Products By News
Summary 89
Table 65: Medtronic, Inc. Pipeline Products by Equipment
Type 93
Table 66: Medtronic, Inc. Pipeline Products By Development
Stage 93
Table 67: Medtronic, Inc. Pipeline Products By Therapy Area
94
Table 68: Medtronic, Inc. Pipeline Products By Clinical Trials
94
Table 69: Eli Lilly and Company Pipeline Products by Equipment
Type 99
Table 70: Eli Lilly and Company Pipeline Products by
Development Stage 99
Table 71: Eli Lilly and Company Pipeline
Products by Therapy Area 99
Table 72: Eli Lilly and Company Pipeline
Products by Clinical Trials 99
Table 73: Eli Lilly and Company
Pipeline Products by News Summary 99
Table 74: AgaMatrix, Inc.
Pipeline Products by Equipment Type 105
Table 75: AgaMatrix, Inc.
Pipeline Products By Development Stage 105
Table 76: AgaMatrix, Inc.
Pipeline Products By Therapy Area 105
Table 77: DexCom, Inc. Pipeline
Products by Equipment Type 106
Table 78: DexCom, Inc. Pipeline
Products By Development Stage 106
Table 79: DexCom, Inc. Pipeline
Products By Therapy Area 107
Table 80: DexCom, Inc. Pipeline Products
By News Summary 107
Table 81: Freedom Meditech, Inc. Pipeline
Products by Equipment Type 108
Table 82: Freedom Meditech, Inc.
Pipeline Products By Development Stage 108
Table 83: Freedom
Meditech, Inc. Pipeline Products By Therapy Area 108
Table 84:
GlucoLight Corporation Pipeline Products by Equipment Type 109
Table 85:
GlucoLight Corporation Pipeline Products By Development Stage 109
Table
86: GlucoLight Corporation Pipeline Products By Therapy Area 109
Table 87: GlucoLight Corporation Pipeline Products By Clinical Trials
110
Table 88: GlucoLight Corporation Pipeline Products By News
Summary 110
Table 89: iSense Corporation Pipeline Products by
Equipment Type 111
Table 90: iSense Corporation Pipeline Products By
Development Stage 111
Table 91: iSense Corporation Pipeline Products
By Therapy Area 112
Table 92: iSense Corporation Pipeline Products By
News Summary 112
Table 93: Sensys Medical, Inc. Pipeline Products by
Equipment Type 113
Table 94: Sensys Medical, Inc. Pipeline Products
By Development Stage 113
Table 95: Sensys Medical, Inc. Pipeline
Products By Therapy Area 114
Table 96: Sensys Medical, Inc. Pipeline
Products By Clinical Trials 114
Table 97: Mediscience Technology
Acquires SensiVida Medical Systems 115
Table 98: Edwards Lifesciences
Enters Into An Agreement With DexCom 116
Table 99: USD to Local
Currency, Average Exchange Rate 2008 132
1.2 List of Figures
Figure 1: United States, Healthcare Expenditure by Source, 2003 19
Figure
2: United States, Healthcare Infrastructure, Top Level View, 2007 24
Figure 3: Healthcare Expenses Segmentation by End User, 2003 25
Figure 4:
Medical Equipment Approval Process in the United States, 2007 32
Figure 5:
PMA Approval Process in the United States, 2007 34
Figure 6: The 510(k)
Approval Process for Medical Devices in the United States, 2007 35
Figure
7: Reimbursement Structure in the United States, 2007 40
Figure 8:
Distribution Structure of Medical Equipment in the United States, 2006 41
Figure 9: Diabetes Care Devices, United States, Overall Revenue ($ mn),
Historic, 2000-2008 42
Figure 10: Diabetes Care Devices, United
States, Overall Revenue ($ mn), Forecast, 2008-2015 43
Figure 11:
Diabetes Care Devices, United States, Category Volume (Units), Historic,
2000-2008 44
Figure 12: Diabetes Care Devices, United States,
Category Volume (Units), Forecast, 2008-2015 45
Figure 13: Diabetes
Care Devices, United States, Cross-Category Analysis, 2000-2015 46
Figure
14: Diabetes Care Devices, United States, Company Share (%), 2007 48
Figure 15: Glucose Monitoring, United States, Revenue ($ mn) by Segment,
Historic, 2000-2008 50
Figure 16: Glucose Monitoring, United States,
Revenue ($ mn) by Segment, Forecast, 2008-2015 51
Figure 17: Blood
Glucose Meters, United States, Revenue ($ mn) by Sub-Segment, Historic,
2000-2008 52
Figure 18: Blood Glucose Meters, United States, Revenue
($ mn) by Sub-Segment, Forecast, 2008-2015 53
Figure 19: Glucose
Monitoring, United States, Cross Segment Analysis, 2000-2015 56
Figure 20:
Glucose Monitoring, United States, Company Share (%), 2007 59
Figure
21: Insulin Delivery, United States, Revenue ($ mn) by Segment, Historic,
2000-2008 61
Figure 22: Insulin Delivery, United States, Revenue ($
mn) by Segment, Forecast, 2008-2015 62
Figure 23: Insulin Delivery,
United States, Cross Segment Analysis, 2000-2015 65
Figure 24:
Insulin Delivery, United States, Company Share (%), 2007 69
Figure 25:
F. Hoffmann-La Roche Ltd Value Chain Analysis 74
Figure 26: Abbott
Laboratories Value Chain Analysis 80
Figure 27: Bayer HealthCare AG
Value Chain Analysis 86
Figure 28: Medtronic, Inc. Value Chain
Analysis 91
Figure 29: Eli Lilly and Company Value Chain Analysis
96
Figure 30: Becton, Dickinson and Company Value Chain Analysis
101
Figure 31: GlobalData Methodology 128
|
有關報告
|
